OSSIUM HEALTH INC
Bioengineered bone and tissue grafts for orthopedic and reconstructive surgery
- Sector
- Biotech
- Headquarters
- San Francisco, CA
- Founded
- 2016
- Latest Form D
- $10.4M, May 2018
- Total capital
- $19M
- Federal grants
- $8.6M
- 17 awards · 2017–2025
- Rank in peer group#20 of 20
- Private capital raised
- $10.4M
- 1 Form D · last May 2018
- 101 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 13
- 27 pending · first 2021
- Rank in peer group#2 of 20
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Developing a bank of purified myeloid progenitor cells as a bridging therapy for transient pancytopenia resulting from radiation injury$1M
- Federal grantHealth and Human S · Phase II · Developing a bank of purified myeloid progenitor cells as a bridging therapy for transient pancytopenia resulting from radiation injury$375K
- Federal grantHealth and Human S · Phase I · Reducing a major cost burden of therapeutic cell manufacturing by selectivelyremoving toxic culture byproducts to allow recycling of media$224K
- Federal grantHealth and Human S · Phase I · A novel approach to Mesenchymal Stem Cell Transduction$248K
- Federal grantHealth and Human S · Phase I · A Novel and Clinically Feasible Co-therapy of Deceased Donor Bone Marrow Combined With Donor-Matched Mesenchymal Stem Cells to Establish Immune Tolerance$142K
- Federal grantHealth and Human S · Phase II · Novel strategies for storage and recovery of cadaveric bone marrow stem cells$687K
- Federal grantHealth and Human S · Phase I · Developing a bank of purified myeloid progenitor cells as a bridging therapy for transient pancytopenia resulting from radiation injury$300K
- Private capital raisedForm D · SEC · 1st filing$10.4M
Show 10 earlier federal awards
- Federal grantHealth and Human S · Phase I · Developing a bank of purified myeloid progenitor cells as a bridging therapy for transient pancytopenia resulting from radiation injury$300K
- Federal grantHealth and Human S · Phase I · A Novel and Clinically Feasible Co-therapy of Deceased Donor Bone Marrow Combined With Donor-Matched Mesenchymal Stem Cells to Establish Immune Tolerance$157K
- Federal grantHealth and Human S · Phase II · Optimizing Industrial-Scale GMP Processes for Recovering and Banking Deceased Donor Bone Marrow$1.0M
- Federal grantHealth and Human S · Phase II · Novel strategies for storage and recovery of cadaveric bone marrow stem cells$779K
- Federal grantHealth and Human S · Phase II · Optimizing Industrial-Scale GMP Processes for Recovering and Banking Deceased Donor Bone Marrow$1.7M
- Federal grantHealth and Human S · Phase II · Optimizing Industrial-Scale GMP Processes for Recovering and Banking Deceased Donor Bone Marrow$683K
- Federal grantHealth and Human S · Phase I · Novel strategies for storage and recovery of cadaveric bone marrow stem cells$225K
- Federal grantHealth and Human S · Phase I · Novel Disaccharide-Based Cryopreservation Approach for Stable, -80°C Storage of Stem Cells$239K
- Federal grantHealth and Human S · Phase I · Deceased Donor Bone Marrow Salvage and Processing$273K
- Federal grantHealth and Human S · Phase I · Deceased Donor Bone Marrow Salvage and Processing$273K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
16months
from OSSIUM HEALTH INC’s first federal award to its first private round.
- First federal award · Feb 2017
- Health and Human S · $273K
- First Form D · May 2018
- $10.4M · 1st Form D
- Awards before first raise
- 4 awards
An association in public records, not a cause or a prediction.
Standing among 20 peers
Line = medianBiotech · Material
- Federal grantsBelow median
- Granted patents#2 · top 10%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Erik WoodsResearcherExecutive Officer, DirectorLinked by 4 patents · $5.6M in grants as PI
- Kevin CaldwellExecutive Officer, DirectorNamed in SEC Form D filings
- Sebastian GiwaDirectorNamed in SEC Form D filings
- Thomas CycyotaDirectorNamed in SEC Form D filings
- William TrenchardDirectorNamed in SEC Form D filings
What it has protected
USPTO · 13 granted of 40- PendingCompositions And Methods Comprising Tissue ImplantsUSPTOApplication 19651150
- GrantedCompositions And Methods For Extraction Of Mesenchymal Stem CellsUSPTOUS 12,698,478
- GrantedSystem And Method For Extraction And Cryopreservation Of Bone MarrowUSPTOUS 12,680,079
Show all 40 patent records
- Compositions And Methods Comprising Tissue ImplantsAug 27, 2026 · Application 19651150Pending
- Compositions And Methods For Extraction Of Mesenchymal Stem CellsAug 4, 2026 · US 12,698,478Granted
- System And Method For Extraction And Cryopreservation Of Bone MarrowJul 14, 2026 · US 12,680,079Granted
- Systems And Methods For Extraction And Cryopreservation Of Bone MarrowJan 22, 2026 · Application 19173541Pending
- Methods And Compositions For Cryopreserving Subpopulations Of LymphocytesSep 4, 2025 · Application 19015356Pending
- Systems And Methods For Extraction And Cryopreservation Of Bone MarrowApr 8, 2025 · US 12,268,207Granted
- Synchronized Mesenchymal Stromal CellsJan 30, 2025 · Application 18913087Pending
- System And Method For Extraction And Cryopreservation Of Bone MarrowAug 15, 2024 · Application 18412312Pending
- Permeation Of Whole Vertebral Bodies With A Cryoprotectant Using Vacuum Assisted DiffusionAug 8, 2024 · Application 18545891Pending
- Compositions And Methods For Extraction Of Mesenchymal Stem CellsJul 18, 2024 · Application 18448864Pending
- Methods Of Cell TherapiesJun 27, 2024 · Application 18456422Pending
- Warming Cryopreserved BoneFeb 13, 2024 · US 11,896,005Granted
- Methods Of Cell TherapiesOct 17, 2023 · US 11,786,558Granted
- Systems And Methods For Extraction And Cryopreservation Of Bone MarrowSep 5, 2023 · US 11,744,243Granted
- System And Method For Extraction And Cryopreservation Of Bone MarrowJul 18, 2023 · US 11,702,637Granted
- System and Method for Extraction and Cryopreservation of Bone MarrowJul 11, 2023 · US 11,697,799Granted
- System And Method For Extraction And Cryopreservation Of Bone MarrowSep 20, 2022 · US 11,447,750Granted
- Methods For Storage Of Stem CellsJun 23, 2022 · Application 17667434Pending
- Compositions And Methods For Extraction Of Mesenchymal Stem CellsJun 16, 2022 · Application 17684277Pending
- Perfusion System For Harvesting Bone MarrowOct 14, 2021 · Application 17227217Pending
- System And Method For Extraction And Cryopreservation Of Bone MarrowAug 31, 2021 · US 11,104,882Granted
- System And Method For Extraction And Cryopreservation Of Bone MarrowAug 10, 2021 · US 11,085,024Granted
- System And Method For Extraction And Cryopreservation Of Bone MarrowJul 15, 2021 · Application 17199376Pending
- System And Method For Extraction And Cryopreservation Of Bone MarrowMay 4, 2021 · US 10,995,318Granted
- Cutting Apparatus For Bioprocessing BoneApr 20, 2021 · US 10,980,547Granted
- Cutting Apparatus for Bioprocessing BoneNov 14, 2019 · Application 16409808Pending
- Permeation Of Whole Vertebral Bodies With ME2SO Using Vacuum Assisted DiffusionApplication 63113777Pending
- Systems And Methods For Extraction And Cryopreservation Of Bone MarrowApplication 63110571Pending
- Compositions And Methods For Extraction Of Mesenchymal CellsApplication 63091904Pending
- Systems And Methods For Extraction And Cryopreservation Of Bone MarrowApplication 63091890Pending
- Permeation Of Whole Vertebral Bodies With ME2SO Using Vacuum Assisted DiffusionApplication 63053585Pending
- Perfusion System for Harvesting Bone MarrowApplication 63008008Pending
- System And Method For Extraction And Cryopreservation Of Bone MarrowApplication PCTUS2020025778Pending
- System and Method for Extraction and Cryopreservation of Bone MarrowApplication 62938480Pending
- System and Method for Collecting and Preserving Bone Marrow for Clinical UseApplication 62834087Pending
- Systems And Methods For Extraction And Cryopreservation Of Bone MarrowApplication 19612305Pending
- Systems And Methods For Extraction And Cryopreservation Of Bone MarrowApplication PCTUS2025014496Pending
- Compositions And Methods Comprising Tissue ImplantsApplication PCTUS2024052039Pending
- Compositions And Methods Comprising Tissue ImplantsApplication 63648406Pending
- Systems And Methods For Extraction And Cryopreservation Of Bone MarrowApplication 63549911Pending
Related companies, and why
- NeuroFx, Inc.Shares a founder: BRIAN JOHNSTONE
- CELLIBRE INCSimilar federal contract value in Biotech · null in contracts
- ALIDA BIOSCIENCES, INC.Similar federal contract value in Biotech · null in contracts
- RODIN THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- NUSIRT SCIENCES, INC.Similar federal contract value in Biotech · null in contracts
- CERSCI THERAPEUTICS INCORPORATEDSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .